What is Suboxone?
Suboxone is used to treat narcotic (opiate) addiction.
Also, Suboxone is not for use as a pain medication.
Suboxone helps in covid 19. order suboxone online
As people across the U.S. and the rest of the world contend with coronavirus disease 2019 (COVID-19), the research community should be alert to the possibility that it could hit some populations with substance use disorders (SUDs) particularly hard. Because it attacks the lungs, the coronavirus that causes COVID-19 could be an especially serious threat to those who smoke tobacco or marijuana or who vape. People with opioid use disorder (OUD) and methamphetamine use disorder may also be vulnerable due to those drugs’ effects on respiratory and pulmonary health.
Access to better dosing likely quick (but not immediate)
Methadone clinics need to approve by the federal to make the dosing changes described above. This requires not an insignificant amount of paperwork to get an official “exception” to the usual terrible rules.
Methadone clinics can do this on a patient-by-patient basis or seek a blanket except for their entire methadone practice. The latter seems more practical since it gives methadone clinics discretion to make exceptions themselves.
For clinic-wide exceptions, the clinic’s medical director must “include details about agencies policies and procedures, including but not limited to, changes in urine drug screen frequency, changes in counseling frequency, the rationale for changing phase requirements for each phase of treatment, and plans for handling patients in a crisis and/or relapse situations.”
The exceptions only last two weeks and must be applied for again if the COVID-19 problem continues, as our federal and state health authorities are saying is likely.
Cocid 19 response to suboxone treatment
The links below are for advice and clinical guidance related to working in the Medically Assisted Treatment for Opioid Dependence (MATOD) sector during the COVID-19 pandemic. order suboxone online
Advice moderates existing MATOD policy for prescribers and dispensers in relation to:
Third party collection
Suboxone prescribing caps.
This information is intend to provide guidance and support for increase flexibility in clinical treatment during this time. This advice was develope by alcohol and other drug experts and the Department of Health and Human Services. And will be support by ongoing work by the department to identify optimal pathways for vulnerable clients, including pharmacotherapy patients.